Peptide Science · 2019 · 17 citations · 25 references
Life SciencesBiochemistryMolecular BiologyCancer PharmacologyDrug DiscoveryMolecular OncologyPeptide ChemistryPeptide Drug DiscoveryProtein Phosphatase SignalingProtein PhosphorylationProtein TargetingD-amino Acid PeptidesNanofibersProtein Self-assembly ScaffoldsSelf-assembling Peptide ScaffoldsTumor-targeting Peptides
Despite multiple new-drug approvals in recent years, prostate cancer remains a global health challenge because of the prostate cancers are resistant to androgen deprivation therapy. Here we show that a small D-phosphopeptide undergoes prostatic acid phosphatase (PAP)-instructed self-assembly for inhibiting castration-resistant prostate cancer (CRPC) cells. Specifically, the installation of phosphate at the C-terminal of a D-tripeptide results in the D-phosphopeptide. Dephosphorylating the D-phosphopeptide by PAP forms uniform nanofibers that inhibit VCaP, a castration-resistant prostate cancer cell. A non-hydrolyzable phosphate analogue of the D-phosphopeptide, which shares similar self-assembling properties with the D-phosphopeptide, confirms that PAP-instructed assembly is critical for the inhibition of VCaP. This work, for the first time, demonstrates PAP-instructed self-assembly of peptides for selective inhibiting castration-resistant prostate cancer (CRPC) cells.
25
A self-assembling peptide acting as an immune adjuvant
Jai S. Rudra, Ye Tian, Jangwook P. Jung et al. · Proceedings of the National Academy of Sciences · 2009 · 520 citations · Full text
Pharmacy, Bioengineering, Immunology +15